PHOENIX — The CartiHeal Agili-C cartilage repair implant had continued improvement in outcomes at 5 years compared with debridement or microfracture, according to results presented here.
“These results show that the implant is resilient. We have persistent good results and we have great return to activity, and we are really pleased with this study,” Kenneth R. Zaslav, MD, director of the Center for Regenerative Orthopedic Medicine at Lennox Hill/Northwell Health, told Healio about results presented at the Arthroscopy Association of North America Annual Meeting.
Zaslav and

ORLANDO — Among adults with mild to severe obstructive sleep apnea, those receiving AD109, an oral combination drug, vs. placebo achieved lower disease severity at 26 weeks, according to pooled phase 3 trial results presented here.
AD109 (Apnimed) is made up of 2.5 mg aroxybutynin, a novel antimuscarinic, and 75 mg atomoxetine, a selective norepinephrine reuptake inhibitor, according to a presentation at the American Thoracic Society International Conference.
“AD109 has been developed as an anti-apneic neuromuscular modulator that’s designed to target the neuromuscular dysfunction that at the

ORLANDO — Urban adolescents with poorly controlled asthma participating in an e-health intervention had improved asthma self-efficacy and fewer days with symptoms immediately following the intervention, according to results presented here.
The Controlling Asthma Program for Adolescents (CAMP Air) is an e-health intervention grounded in social cognitive theory that uses motional interviewing, according to the presentation at the American Thoracic Society International Conference.
“Immediately after the intervention, CAMP Air resulted in more confidence to manage asthma, greater reported control